Literature DB >> 9074577

Tissue-factor antigen and activity in human coronary atherosclerotic plaques.

D Ardissino1, P A Merlini, R Ariëns, R Coppola, E Bramucci, P M Mannucci.   

Abstract

BACKGROUND: Coronary atherosclerotic-plaque thrombosis is a key event in the pathogenesis of unstable angina and myocardial infarction. Although plaque rupture or fissuring frequently occurs in atherosclerosis, only a small proportion of ruptured plaques develop thromboses.
METHODS: Tissue-factor antigen and activity were measured in atherectomy samples from 50 consecutive patients with coronary artery disease (stable angina n = 19, unstable angina n = 24, and myocardial infarction n = 7).
FINDINGS: Median tissue-factor antigen and activity concentrations were significantly higher in plaques from patients with unstable angina and myocardial infarction than in those from patients with stable angina (antigen: 66.1 pg/mg [interquartile range 43.8-82.5] vs 32.4 pg/mg [9.8-43.4], p = 0.0001; activity: 0.22 mU/mg [0.17-0.41] vs 0.13 mU/mg [0.05-0.16], p = 0.0004).
INTERPRETATION: Tissue-factor, an initiator of the coagulation cascade, may account for the different thrombotic responses to the rupture of human coronary atherosclerotic plaques.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9074577     DOI: 10.1016/S0140-6736(96)11189-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  24 in total

1.  Can we stabilize unstable plaque?

Authors:  Rodolfo Paoletti; Andrea Cignarella
Journal:  Curr Atheroscler Rep       Date:  2003-11       Impact factor: 5.113

Review 2.  Roles of Coagulation Proteases and PARs (Protease-Activated Receptors) in Mouse Models of Inflammatory Diseases.

Authors:  Jens J Posma; Steven P Grover; Yohei Hisada; A Phillip Owens; Silvio Antoniak; Henri M Spronk; Nigel Mackman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-01       Impact factor: 8.311

3.  Tissue factor levels in type 2 diabetes mellitus.

Authors:  Prashilla Soma; Albe C Swanepoel; Janette Bester; Etheresia Pretorius
Journal:  Inflamm Res       Date:  2017-02-28       Impact factor: 4.575

4.  Combined effects of irbesartan and carvedilol on expression of tissue factor and tissue factor pathway inhibitor in rats after myocardial infarction.

Authors:  Junmin Yu; Jiyi Zhao; Wei Liu; Zhenzhong Ge; Yongli Du
Journal:  Heart Vessels       Date:  2011-01-13       Impact factor: 2.037

5.  Tissue Factor, Tissue Factor Pathway Inhibitor and Factor VII Activity in Cardiovascular Complicated Type 2 Diabetes Mellitus.

Authors:  Rehab S El-Hagracy; Gihan M Kamal; Inas M Sabry; Abeer A Saad; Nahla F Abou El Ezz; Hesham A R Nasr
Journal:  Oman Med J       Date:  2010-07

Review 6.  Role of tissue factor in atherothrombosis.

Authors:  A Phillip Owens; Nigel Mackman
Journal:  Curr Atheroscler Rep       Date:  2012-10       Impact factor: 5.113

Review 7.  The impact of heparin compounds on cellular inflammatory responses: a construct for future investigation and pharmaceutical development.

Authors:  Essam Elsayed; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2003-02       Impact factor: 2.300

Review 8.  Tissue factor; from Morawitz to microparticles.

Authors:  Nigel S Key; Jian-Guo Geng; Ronald R Bach
Journal:  Trans Am Clin Climatol Assoc       Date:  2007

9.  Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice.

Authors:  Giuseppina Caligiuri; Mats Rudling; Véronique Ollivier; Marie-Paule Jacob; Jean-Baptiste Michel; Göran K Hansson; Antonino Nicoletti
Journal:  Mol Med       Date:  2003 Jan-Feb       Impact factor: 6.354

10.  Inhibition of acute vascular thrombosis in chimpanzees by an anti-human tissue factor antibody targeting the factor X binding site.

Authors:  Jin-an Jiao; Andrew B Kelly; Ulla M Marzec; Esperanza Nieves; Jorge Acevedo; Martin Burkhardt; Ana Edwards; Xiao-yun Zhu; Pierre-Andre Chavaillaz; Alice Wong; Jeffrey L Wong; Jack O Egan; Dean Taylor; Peter R Rhode; Hing C Wong
Journal:  Thromb Haemost       Date:  2009-10-26       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.